Regulation of the osterix (Osx, Sp7) promoter by osterix and its inhibition by parathyroid hormone

Journal of Molecular Endocrinology

Volumn 51, Issue 1, 2013, Pages 99-108

  Barbuto, Richard ^a   Mitchell, Jane ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Autoregulation; Osteoblasts; Osterix; Parathyroid hormone; Sp factor

Indexed keywords

KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 10; MESSENGER RNA; MITHRAMYCIN; MITHRAMYCIN A; MITOGEN ACTIVATED PROTEIN KINASE P38; PARATHYROID HORMONE; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SEQUENCE; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; TANDEM REPEAT; TRANSCRIPTION REGULATION;

AUTOREGULATION; OSTEOBLASTS; OSTERIX; PARATHYROID HORMONE; SP FACTOR;

ANIMALS; BINDING SITES; GENE EXPRESSION REGULATION; MICE; OSTEOBLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PARATHYROID HORMONE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RATS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84879313883     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-12-0251     Document Type: Article

References (32)

1. Baek WY, Lee MA, Jung JW, Kim SY, Akiyama H, de Crombrugghe B & Kim JE 2009 Positive regulation of adult bone formation by osteoblast-specific transcription factor osterix. Journal of Bone and Mineral Research 24 1055-1065. (doi:10.1359/jbmr.081248)
2. Bianchi EN & Ferrari SL 2009 b-Arrestin2 regulates parathyroid hormone effects on a p38 MAPK and NFkappaB gene expression network in osteoblasts. Bone 45 716-725. (doi:10.1016/j.bone.2009.06.020)
3. Blume SW, Snyder RC, Ray R, Thomas S, Koller CA & Miller DM 1991 Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. Journal of Clinical Investigation 88 1613-1621. (doi:10.1172/JCI115474)
4. Celil AB & Campbell PG 2005 BMP-2 and insulin-like growth factor-Imediate Osterix (Osx) expression in human mesenchymal stem cellsvia the MAPK and protein kinase D signaling pathways. Journal ofBiological Chemistry 280 31353-31359. (doi:10.1074/jbc.M503845200)
5. Cuadrado A & Nebreda AR 2010 Mechanisms and functions of p38 MAPKsignalling. Biochemical Journal 429 403-417. (doi:10.1042/BJ20100323)
6. Doggett TA, Swarthout JT, Jefcoat SC Jr, Wilhelm D, Dieckmann A, Angel P& Partridge NC 2002 Parathyroid hormone inhibits c-Jun N-terminalkinase activity in rat osteoblastic cells by a protein kinase A-dependentpathway. Endocrinology 143 1880-1888. (doi:10.1210/en.143.5.1880)
7. Fu H, Doll B, McNelis T & Hollinger JO 2007 Osteoblast differentiationin vitro and in vivo promoted by Osterix. Journal of Biomedical MaterialsResearch. Part A 83 770-778. (doi:10.1002/jbm.a.31356)
8. Gao Y, Jheon A, Nourkeyhani H, Kobayashi H & Ganss B 2004 Molecularcloning, structure, expression, and chromosomal localization of thehuman Osterix (SP7) gene. Gene 341 101-110. (doi:10.1016/j.gene.2004.05.026)
9. Gilbert L, He X, Farmer P, Boden S, Kozlowski M, Rubin J & Nanes MS 2000 Inhibition of osteoblast differentiation by tumor necrosis factor-a. Endocrinology 141 3956-3964. (doi:10.1210/en.141.11.3956)
10. Greenblatt MB, Shim JH, Zou W, Sitara D, Schweitzer M, Hu D, Lotinun S, Sano Y, Baron R, Park JM et al. 2010 The p38 MAPK pathway is essentialfor skeletogenesis and bone homeostasis in mice. Journal of ClinicalInvestigation 120 2457-2473. (doi:10.1172/JCI42285)
11. Hong SH, Lu X, Nanes MS & Mitchell J 2009 Regulation of osterix(Osx, Sp7) and the Osx promoter by parathyroid hormone inosteoblasts. Journal of Molecular Endocrinology 43 197-207. (doi:10.1677/JME-09-0012)
12. Kurata H, Guillot PV, Chan J & Fisk NM 2007 Osterix induces osteogenicgene expression but not differentiation in primary human fetalmesenchymal stem cells. Tissue Engineering 13 1513-1523. (doi:10.1089/ten.2006.0374)
13. Lai LP & Mitchell J 2009 Parathyroid hormone inhibits phosphorylationof mitogen-activated protein kinase (MAPK) ERK1/2 through inhibitionof c-Raf and activation of MKP-1 in osteoblastic cells. Cell Biochemistryand Function 27 269-275. (doi:10.1002/cbf.1568)
14. Lai LP, DaSilva KA & Mitchell J 2005 Regulation of Indian hedgehog mRNAlevels in chondrocytic cells by ERK1/2 and p38 mitogen-activatedprotein kinases. Journal of Cellular Physiology 203 177-185. (doi:10.1002/jcp.20208)
15. Lapunzina P, Aglan M, Temtamy S, Caparros-Martin JA, Valencia M, Leton R, Martinez-Glez V, Elhossini R, Amr K, Vilaboa N et al. 2010 Identification of a frameshift mutation in Osterix in a patient withrecessive osteogenesis imperfecta. American Journal of Human Genetics 87 110-114. (doi:10.1016/j.ajhg.2010.05.016)
16. Lee MH, Javed A, Kim HJ, Shin HI, Gutierrez S, Choi JY, Rosen V, Stein JL, van Wijnen AJ, Stein GS et al. 1999 Transient upregulation of CBFA1 inresponse to bone morphogenetic protein-2 and transforming growthfactor b1 in C2C12 myogenic cells coincides with suppression of themyogenic phenotype but is not sufficient for osteoblast differentiation. Journal of Cellular Biochemistry 73 114-125. (doi:10.1002/(SICI) 1097-4644(19990401) 73:1!114::AID-JCB13O3.0.CO;2-M)
17. Lee MH, Kwon TG, Park HS, Wozney JM & Ryoo HM 2003 BMP-2-inducedOsterix expression is mediated by Dlx5 but is independent of Runx2. Biochemical and Biophysical Research Communications 309 689-694. (doi:10.1016/j.bbrc.2003.08.058)
18. Lu X, Gilbert L, He X, Rubin J & Nanes MS 2006 Transcriptional regulationof the osterix (Osx, Sp7) promoter by tumor necrosis factor identifiesdisparate effects of mitogen-activated protein kinase and NF kappa Bpathways. Journal of Biological Chemistry 281 6297-6306. (doi:10.1074/jbc.M507804200)
19. Lu X, Beck GR Jr, Gilbert LC, Camalier CE, Bateman NW, Hood BL, Conrads TP, Kern MJ, You S, Chen H et al. 2011 Identification of thehomeobox protein Prx1 (MHox, Prrx-1) as a regulator of osterixexpression and mediator of tumor necrosis factor a action inosteoblast differentiation. Journal of Bone and Mineral Research 26209-26219. (doi:10.1002/jbmr.203)
20. Matthews J, Wihlen B, Thomsen J & Gustafsson JA 2005 Aryl hydrocarbonreceptor-mediated transcription: ligand-dependent recruitment ofestrogen receptor a to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsivepromoters. Molecular and Cellular Biology 25 5317-5328. (doi:10.1128/MCB.25.13.5317-5328.2005)
21. Miller DM, Polansky DA, Thomas SD, Ray R, Campbell VW, Sanchez J & Koller CA 1987 Mithramycin selectively inhibits transcription of G-Ccontaining DNA. American Journal of the Medical Sciences 294 388-394. (doi:10.1097/00000441-198711000-00015)
22. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR & deCrombrugghe B 2002 The novel zinc finger-containing transcriptionfactor osterix is required for osteoblast differentiation and boneformation. Cell 108 17-29. (doi:10.1016/S0092-8674(01) 00622-5)
23. Ortuno MJ, Ruiz-Gaspa S, Rodriguez-Carballo E, Susperregui AR, Bartrons R, Rosa JL & Ventura F 2010 p38 regulates expression of osteoblast-specificgenes by phosphorylation of osterix. Journal of Biological Chemistry 285 31985-31994. (doi:10.1074/jbc.M110.123612)
24. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B & Davis RJ 1996MKK3- and MKK6-regulated gene expression is mediated by the p38mitogen-activated protein kinase signal transduction pathway. Molecular and Cellular Biology 16 1247-1255.
25. Rey A, Manen D, Rizzoli R, Ferrari SL & Caverzasio J 2007 Evidences fora role of p38 MAP kinase in the stimulation of alkaline phosphataseand matrix mineralization induced by parathyroid hormonein osteoblastic cells. Bone 41 59-67. (doi:10.1016/j.bone.2007.02.031)
26. Timpson NJ, Tobias JH, Richards JB, Soranzo N, Duncan EL, Sims AM, Whittaker P, Kumanduri V, Zhai G, Glaser B et al. 2009 Commonvariants in the region around Osterix are associated with bonemineral density and growth in childhood. Human Molecular Genetics18 1510-1517. (doi:10.1093/hmg/ddp052)
27. Ulsamer A, Ortuno MJ, Ruiz S, Susperregui AR, Osses N, Rosa JL & Ventura F 2008 BMP-2 induces Osterix expression through up-regulation of Dlx5and its phosphorylation by p38. Journal of Biological Chemistry 283 3816-3826. (doi:10.1074/jbc.M704724200)
28. Wong GL & Cohn DV 1975 Target cells in bone for parathormone andcalcitonin are different: enrichment for each cell type by sequentialdigestion of mouse calvaria and selective adhesion to polymericsurfaces. PNAS 72 3167-3171. (doi:10.1073/pnas.72.8.3167)
29. Wu YF, Matsuo N, Sumiyoshi H & Yoshioka H 2010 Sp7/Osterix is involvedin the up-regulation of the mouse pro-a1(V) collagen gene (Col5a1) inosteoblastic cells. Matrix Biology 29 701-706. (doi:10.1016/j.matbio.2010.09.002)
30. Zhen X, Wei L, Wu Q, Zhang Y & Chen Q 2001 Mitogen-activated proteinkinase p38 mediates regulation of chondrocyte differentiation byparathyroid hormone. Journal of Biological Chemistry 276 4879-4885. (doi:10.1074/jbc.M004990200)
31. Zheng C, Xiang J, Hunter T & Lin A 1999 The JNKK2-JNK1 fusion proteinacts as a constitutively active c-Jun kinase that stimulates c-Juntranscription activity. Journal of Biological Chemistry 274 28966-28971. (doi:10.1074/jbc.274.41.28966)
32. Zhou X, Zhang Z, Feng JQ, Dusevich VM, Sinha K, Zhang H, Darnay BG & de Crombrugghe B 2010 Multiple functions of Osterix are requiredfor bone growth and homeostasis in postnatal mice. PNAS 10712919-12924. (doi:10.1073/pnas.0912855107)